APP and early-onset autosomal dominant Alzheimer disease: For example, icariin exerts neuroprotective effects via modulating the CD4+ T lymphocyte-related immunoinflammatory responses in APP/PS1 mice and may be a promising drug against Alzheimer’s disease progression [83].